Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116
- PMID: 21115903
Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116
Abstract
Genistein (GEN), one of the soy isoflavones, exhibits protection against colon cancer. The WNT signaling pathway plays a critical role in both normal epithelial regeneration and tumorigenesis in human colon. In this study it was hypothesized that GEN regulates specific genes in the WNT signaling pathway. Colon cancer cell lines DLD-1, SW480, and SW1116 were treated with Novasoy or GEN for 4 days. mRNA levels of several WNT signaling components were analyzed by real-time PCR. Methylation-specific PCR and bisulfite genomic sequencing were used to analyze the methylation status of CpG islands. Both Novasoy and GEN inhibited cell proliferation in all three cell lines. WNT5a mRNA showed a time-dependent induction by Novasoy and GEN in DLD-1 cells but only by GEN in SW1116 cells. Meanwhile, WNT5a CpG island methylation level was decreased in SW1116 by GEN. In conclusion, GEN regulated WNT5a expression, which was accompanied by a decrease in DNA methylation level at the analyzed CpG island.
Similar articles
-
DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development.Carcinogenesis. 2013 Aug;34(8):1756-63. doi: 10.1093/carcin/bgt129. Epub 2013 Apr 18. Carcinogenesis. 2013. PMID: 23598468 Free PMC article.
-
Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.PLoS One. 2016 Mar 15;11(3):e0151392. doi: 10.1371/journal.pone.0151392. eCollection 2016. PLoS One. 2016. PMID: 26978652 Free PMC article.
-
WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.Cancer Biol Ther. 2010 Sep 15;10(6):617-24. doi: 10.4161/cbt.10.6.12609. Epub 2010 Sep 7. Cancer Biol Ther. 2010. PMID: 20603606
-
Genistein, an epigenome modifier during cancer prevention.Epigenetics. 2011 Jul;6(7):888-91. doi: 10.4161/epi.6.7.16315. Epub 2011 Jul 1. Epigenetics. 2011. PMID: 21610327 Review.
-
DING, a genistein target in human breast cancer: a protein without a gene.J Nutr. 2003 Jul;133(7 Suppl):2497S-2501S. doi: 10.1093/jn/133.7.2497S. J Nutr. 2003. PMID: 12840230 Review.
Cited by
-
Rear-polarized Wnt5a-receptor-actin-myosin-polarity (WRAMP) structures promote the speed and persistence of directional cell migration.Mol Biol Cell. 2017 Jul 7;28(14):1924-1936. doi: 10.1091/mbc.E16-12-0875. Epub 2017 Jun 7. Mol Biol Cell. 2017. PMID: 28592632 Free PMC article.
-
EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.J Cancer Res Clin Oncol. 2017 Nov;143(11):2211-2219. doi: 10.1007/s00432-017-2479-2. Epub 2017 Jul 26. J Cancer Res Clin Oncol. 2017. PMID: 28748258 Free PMC article.
-
Impact of soy isoflavones on the epigenome in cancer prevention.Nutrients. 2014 Oct 15;6(10):4218-72. doi: 10.3390/nu6104218. Nutrients. 2014. PMID: 25322458 Free PMC article. Review.
-
Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.BMC Cancer. 2011 Jun 3;11:219. doi: 10.1186/1471-2407-11-219. BMC Cancer. 2011. PMID: 21639915 Free PMC article.
-
Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits.Oxid Med Cell Longev. 2021 Jul 19;2021:3268136. doi: 10.1155/2021/3268136. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34336089 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous